HELP · Helus Pharma Inc
United States · RS rating 56 · As of 2026-11-03
| Price | 9.03 USD |
|---|---|
| 1-day change | +2.6% |
| RS rating (overall / 1M / 3M / 12M) | 56 / 20 / 38 / 71 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 27 / 34 / 35 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +28.1% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +35.6% |
| Market cap (USD) | $286.9M |